A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

This study is currently recruiting participants.

Verified March 2013 by Grifols Therapeutics Inc.

Study NCT01014975 Information provided by Grifols Therapeutics Inc.

First Received on November 16, 2009. Last Updated on March 11, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Cerebral Infarction
Ischemia
Stroke

More general conditions related to this trial

Interventions listed in this trial

Plasmin (Human)

Additional drug interventions recognized in this trial

Fibrinolysin

More general drug interventions related to this trial

Sponsors listed in this trial